Characteristics of Long COVID-19 Syndrome
Study Details
Study Description
Brief Summary
Characterization of patients with long COVID syndrome including symptoms, medical history and persistent organ damage.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Some people are very hesitant to recover from a COVID-19 infection and present persistent symptoms. The participants still suffer after the acute phase of the infection from shortness of breath, coughing, chest pain or fatigue. Therefore, a special interdisciplinary consultation was built. The consulatation is not only addressed to people who have been hospitalized due to COVID-19, but also to those with mild symptoms during infection. During the consultation hours, personal health data are collected that serves as the basis for this research project.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Long COVID Patients with long COVID syndrome |
Other: No intervention
no intervention
|
Outcome Measures
Primary Outcome Measures
- Dyspnea [once through study completion, an average of 6 months.]
modified medical research council (scale from 0 to 4). The higher the score the worse the symptoms.
- self-addressed Quality of life [once through study completion, an average of 6 months]
Short form health 36 questionnaire with 8 domains, each rated from 0-100. The higher the score the better subjective quality of life.
- Thoracic pain [once through study completion, an average of 6 months]
assessed by medical interview (reported as yes or no)
- Medical history [once through study completion, an average of 6 months]
List of relevant morbidities assessed as present/not present by medical interview (e.g. respiratory, cardial, neurological, psychiatric diseases by interview and medical records)
- Fibrosis [once through study completion, an average of 6 months]
Assessed by chest CT, rated as present/not present
- Myocardial damage [once through study completion, an average of 6 months]
Assessed by myocardial damage, rated as present/not present
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Long COVID syndrome
-
age >= 18 years
-
Informed consent
Exclusion Criteria:
- none
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Hospital Zurich | Zurich | Switzerland | 8091 |
Sponsors and Collaborators
- Christian Clarenbach
Investigators
- Study Chair: Christian F Clarenbach, MD, University Hospital Zurich, Pulmonology
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2021-00280